These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 27191265)
1. Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP2/3. Jia J; Li F; Tang XS; Xu S; Gao Y; Shi Q; Guo W; Wang X; He D; Guo P Oncotarget; 2016 Jun; 7(25):37868-37881. PubMed ID: 27191265 [TBL] [Abstract][Full Text] [Related]
2. The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription. Zhang KJ; Tan XL; Guo L Mol Oncol; 2020 Feb; 14(2):309-328. PubMed ID: 31860165 [TBL] [Abstract][Full Text] [Related]
3. LncRNA DANCR promotes migration and invasion through suppression of lncRNA-LET in gastric cancer cells. Mao Z; Li H; Du B; Cui K; Xing Y; Zhao X; Zai S Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28951520 [TBL] [Abstract][Full Text] [Related]
4. lncRNA ABHD11-AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2. Zeng XY; Jiang XY; Yong JH; Xie H; Yuan J; Zeng D; Dou YY; Xiao SS Cancer Med; 2019 Nov; 8(16):7074-7085. PubMed ID: 31568657 [TBL] [Abstract][Full Text] [Related]
5. EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion. Yi X; Guo J; Guo J; Sun S; Yang P; Wang J; Li Y; Xie L; Cai J; Wang Z Sci Rep; 2017 Jun; 7(1):3568. PubMed ID: 28620234 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer. Bai Y; Zhang Z; Cheng L; Wang R; Chen X; Kong Y; Feng F; Ahmad N; Li L; Liu X J Biol Chem; 2019 Jun; 294(25):9911-9923. PubMed ID: 31085587 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA DANCR regulates proliferation and migration by epigenetically silencing FBP1 in tumorigenesis of cholangiocarcinoma. Wang N; Zhang C; Wang W; Liu J; Yu Y; Li Y; Zhang M; Ge X; Li Q; Miao L Cell Death Dis; 2019 Aug; 10(8):585. PubMed ID: 31383847 [TBL] [Abstract][Full Text] [Related]
8. The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells. Shin YJ; Kim JH PLoS One; 2012; 7(1):e30393. PubMed ID: 22272343 [TBL] [Abstract][Full Text] [Related]
9. Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition. Liu C; Lou W; Armstrong C; Zhu Y; Evans CP; Gao AC Prostate; 2015 Sep; 75(13):1341-53. PubMed ID: 25970160 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429. Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494 [TBL] [Abstract][Full Text] [Related]
11. Novel lncRNA Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol Suppresses Human Nasopharyngeal Carcinoma Cell Growth Via Inhibiting Differentiation Antagonizing Non-Protein Coding RNA (DANCR) Expression. Zhang J; Jin X; Zhou C; Zhao H; He P; Hao Y; Dong Q Med Sci Monit; 2020 Jul; 26():e923622. PubMed ID: 32683392 [TBL] [Abstract][Full Text] [Related]
13. Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. Li L; Dang Q; Xie H; Yang Z; He D; Liang L; Song W; Yeh S; Chang C Oncotarget; 2015 Jun; 6(16):14179-90. PubMed ID: 25895025 [TBL] [Abstract][Full Text] [Related]
14. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2. Zhou Y; Yang H; Xia W; Cui L; Xu R; Lu H; Xue D; Tian Z; Ding T; Cao Y; Shi Q; He X J Biochem; 2020 Mar; 167(3):295-301. PubMed ID: 31790140 [TBL] [Abstract][Full Text] [Related]
15. ASC-J9(®), and not Casodex or Enzalutamide, suppresses prostate cancer stem/progenitor cell invasion via altering the EZH2-STAT3 signals. Wen S; Tian J; Niu Y; Li L; Yeh S; Chang C Cancer Lett; 2016 Jul; 376(2):377-86. PubMed ID: 27045473 [TBL] [Abstract][Full Text] [Related]
16. Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9 Wang R; Sun Y; Li L; Niu Y; Lin W; Lin C; Antonarakis ES; Luo J; Yeh S; Chang C Eur Urol; 2017 Nov; 72(5):835-844. PubMed ID: 28528814 [TBL] [Abstract][Full Text] [Related]
17. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer. Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691 [TBL] [Abstract][Full Text] [Related]
18. Natural killer cells suppress enzalutamide resistance and cell invasion in the castration resistant prostate cancer via targeting the androgen receptor splicing variant 7 (ARv7). Lin SJ; Chou FJ; Li L; Lin CY; Yeh S; Chang C Cancer Lett; 2017 Jul; 398():62-69. PubMed ID: 28373004 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells. Wang K; Chen Z; Shi J; Feng Y; Yu M; Sun Y; Zhuang Q; Liang B; Luo G; Xu X; Fan M Prostate; 2020 Sep; 80(12):977-985. PubMed ID: 32542727 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of long noncoding RNA TUG1 by EGR1 promotes adenomyotic epithelial cell migration and invasion through recruiting EZH2 and suppressing TIMP2. Shi B; Tu H; Sha L; Luo X; Wu W; Su Y; Yang S; Wang H Mol Reprod Dev; 2019 Feb; 86(2):239-247. PubMed ID: 30593723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]